# Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)

> **NCT07216859** · NA · NOT_YET_RECRUITING · sponsor: **Kaiser Permanente** · enrollment: 2000 (estimated)

## Conditions studied

- MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
- Cirrhosis

## Interventions

- **OTHER:** AI-Enabled Identification (EchoNet-Liver)

## Key facts

- **NCT ID:** NCT07216859
- **Lead sponsor:** Kaiser Permanente
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2027-11-01
- **Final completion:** 2027-11-01
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-11-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07216859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07216859, "Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07216859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*